Recruiting NA INTERVENTIONAL 2-arm
NCT07184307
Platelet-Rich Plasma Versus Botulinum Toxin for Refractory Overactive Bladder: A Randomized Trial
Intra-vesical Injection of Platelet-Rich Plasma Compared With Botox for Management of Patients With Refractory Overactive Bladder: A Comparative Randomized Study
Sponsor: Benha University
Interventions
Intravesical Botulinum Toxin Injection Platelet-Rich Plasma
Updated 1 time since 2025 Last updated: Sep 13, 2025 Started: Apr 15, 2025 Primary completion: Apr 15, 2026 Completion: Apr 15, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
This NA trial investigates Detrusor Overactivity and Overactive Bladder Syndrome and is currently actively recruiting participants. Benha University leads this study, which shows 1 recorded version since 2025 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
1 version recorded Recruiting — NA
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Benha University
Data source: Benha University
For direct contact, visit the study record on ClinicalTrials.gov .